⌘K

Home/Filings/4/0000899243-19-016413

4//SEC Filing

Daniel Thomas O 4

Accession 0000899243-19-016413

CIK 0001690585other

View on SEC.gov Company Profile

Filed

Jun 10, 8:00 PM ET

Accepted

Jun 11, 5:06 PM ET

Size

5.4 KB

Accession

0000899243-19-016413

Insider Transaction Report

Form 4

Period: 2019-06-07

Magenta Therapeutics, Inc.MGTA

Daniel Thomas O

Director

Transactions

Award
Stock Option (Right to Buy)
2019-06-07+18,188→ 18,188 total
Exercise: $13.40Exp: 2029-06-06→ Common Stock (18,188 underlying)

Footnotes (1)

[F1]This option shall vest and become exercisable in full upon the earlier to occur of (a) June 7, 2020 or (b) the next annual meeting of the Issuer's stockholders.

Documents

1 file

4
doc4.xmlPrimary
FORM 4 SUBMISSION

Issuer

Magenta Therapeutics, Inc.

CIK 0001690585

Entity typeother

Related Parties

1

filerCIK 0001538894

Filing Metadata

Form type: 4
Filed: Jun 10, 8:00 PM ET
Accepted: Jun 11, 5:06 PM ET
Size: 5.4 KB

View on SEC.gov